Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Thermogenesis stock
Learn how to easily invest in Thermogenesis stock.
Thermogenesis is a medical devices business based in the US. Thermogenesis shares (THMO) are listed on the NASDAQ and all prices are listed in US Dollars. Thermogenesis employs 39 staff and has a trailing 12-month revenue of around $10.2 million.
How to buy Thermogenesis stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – THMO. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Commission-free trading
- Commission-free crypto
- No minimum account balance
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Thermogenesis stock price (NASDAQ: THMO)Use our graph to track the performance of THMO stocks over time.
Thermogenesis shares at a glance
|Latest market close||$5.08|
|52-week range||$2.67 - $45.00|
|50-day moving average||$4.41|
|200-day moving average||$11.57|
|Wall St. target price||$45.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.91|
Buy Thermogenesis stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Thermogenesis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Thermogenesis price performance over time
|1 week (2023-01-19)||43.50%|
|1 month (2022-12-27)||78.25%|
|3 months (2022-10-27)||4,980.00%|
|6 months (2022-07-27)||2,440.00%|
|1 year (2022-01-27)||497.65%|
|2 years (2021-01-27)||88.85%|
|3 years (2020-01-27)||5.33|
|5 years (2018-01-26)||72.21%|
|Revenue TTM||$10.2 million|
|Gross profit TTM||$3.5 million|
|Return on assets TTM||-17.47%|
|Return on equity TTM||-213.24%|
|Market capitalisation||$3.5 million|
TTM: trailing 12 months
Thermogenesis share dividends
We're not expecting Thermogenesis to pay a dividend over the next 12 months.
Have Thermogenesis's shares ever split?
Thermogenesis's shares were split on a 1:45 basis on 21 December 2022. So if you had owned 45 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Thermogenesis shares – just the quantity. However, indirectly, the new 4400% higher share price could have impacted the market appetite for Thermogenesis shares which in turn could have impacted Thermogenesis's share price.
Thermogenesis share price volatility
Over the last 12 months, Thermogenesis's shares have ranged in value from as little as $2.67 up to $45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Thermogenesis's is 2.5368. This would suggest that Thermogenesis's shares are significantly more volatile than the average for this exchange and represent a higher risk.
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc.
Frequently asked questionsWhat percentage of Thermogenesis is owned by insiders or institutions?
Currently 26.316% of Thermogenesis shares are held by insiders and 1.327% by institutions. How many people work for Thermogenesis?
Latest data suggests 39 work at Thermogenesis. When does the fiscal year end for Thermogenesis?
Thermogenesis's fiscal year ends in December. Where is Thermogenesis based?
Thermogenesis's address is: 2711 Citrus Road, Rancho Cordova, CA, United States, 95742 What is Thermogenesis's ISIN number?
Thermogenesis's international securities identification number is: US88362L1008 What is Thermogenesis's CUSIP number?
Thermogenesis's Committee on Uniform Securities Identification Procedures number is: 883623209
More guides on Finder
How to buy TXO Energy (TXO) stock when it goes public
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock when it goes public
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert